Analytical Data
-
基因名
SDHAF2
- Application
-
别名
SDHAF2;C11orf79;PGL2;SDH5;Succinate dehydrogenase assembly factor 2. mitochondrial
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NX18
-
表达区间
30-166aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MGSSFRRFYR GDSPTDSQKD MIEIPLPPWQ ERTDESIETK RARLLYESRK RGMLENCILL SLFAKEHLQH MTEKQLNLYD RLINEPSNDW DIYYWATEAK PAPEIFENEV MALLRDFAKN KNKEQRLRAP DLEYLFEKPR
-
分子量
19 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SDHAF2, or succinate dehydrogenase assembly factor 2, has emerged as a critical protein in the context of mitochondrial biology and cellular metabolism. It plays an essential role in the assembly and maturation of succinate dehydrogenase (SDH), a key enzyme complex in the mitochondrial respiratory chain that links the tricarboxylic acid cycle to oxidative phosphorylation. Dysfunctions in SDH and its assembly factors, including SDHAF2, have been implicated in various metabolic disorders and cancers, particularly in tumors characterized by mitochondrial dysfunction. Thus, understanding the mechanism of SDHAF2 and its interactions within the assembly of SDH is crucial for elucidating the pathophysiology of these conditions. Recent studies have highlighted the importance of SDHAF2 not only in enzyme assembly but also in maintaining mitochondrial integrity and function. Targeting SDHAF2 may provide new therapeutic avenues for diseases linked to mitochondrial dysfunction. Furthermore, the exploration of its structure, interaction partners, and regulatory mechanisms is vital for the potential development of molecular interventions aimed at restoring normal SDH function in affected tissues. Ongoing research on SDHAF2 thus represents a promising frontier in both cancer biology and metabolic research, warranting further investigation into its molecular roles and therapeutic potential.












